Upload
phamngoc
View
218
Download
5
Embed Size (px)
Citation preview
Republic of the Philippines Department of Health
Food and Drug Administration
Guidelines on the Implementation of New
Rules and Regulations on the Licensing of
Drug Manufacturer and its Subclass (Packer/
Repacker/ Trader) following Administrative
Order No. 2014-00xx, dated xx
Center for Drug Regulation and Research Media Room, 1st Floor, Main Building
Civic Drive, Filinvest Corporate City, Alabang, Muntinlupa City
17 September 2014
1
Presentation Outline
A. Objectives of Meeting
B. Draft Regulation
C. Discussion
Center for Drug Regulation and Research 2
Regulation Outline
I. Rationale
II. LTO Applications
III.Exemption in Providing Another Pharmacist for Additional Licensed Activity
IV.Responsiblities of Implementing Offices
Center for Drug Regulation and Research 3
Regulation Outline
V. Transitory Provisions
VI. Repealing/Separability Clause
VII. Effectivity
VIII.Annex A: Requirements
IX. Annex B: Variations
Center for Drug Regulation and Research 4
Republic of the Philippines Department of Health
Food and Drug Administration
Center for Drug Regulation and Research 5
A. OBJECTIVES OF THE MEETING
Objectives of the Meeting
Discuss the draft regulation
Gather inputs/suggestions from stakeholders
Test run the proposed forms for application
Center for Drug Regulation and Research 6
Republic of the Philippines Department of Health
Food and Drug Administration
Center for Drug Regulation and Research 7
B. DRAFT REGULATION
Republic of the Philippines Department of Health
Food and Drug Administration
Center for Drug Regulation and Research 8
RATIONALE
Manufacturer Regulation
Rationale
requirements for the applications for initial and renewal issuance of License to Operate (LTO), variations, as well as other guidelines relevant to these establishments
Center for Drug Regulation and Research 9
Republic of the Philippines Department of Health
Food and Drug Administration
Center for Drug Regulation and Research 10
LTO APPLICATION
Manufacturer Regulation
A. Documentary Requirements
(1) Application Form
Completely filled-up
signed by the authorized personnel
duly notarized
Center for Drug Regulation and Research 11
A. Documentary Requirements
(2) Proof of Business Name Registration
For single proprietorship - Certificate of Business Registration issued by DTI
For corporation, partnership and other juridical person - Certificate of Registration issued by SEC and Articles of Incorporation
Center for Drug Regulation and Research 12
A. Documentary Requirements
(2) Proof of Business Name Registration
For cooperative - Certificate of Registration issued by the Cooperative Development Authority and the approved by-laws
For government-owned or controlled corporation - the law highlighting the provision creating such establishment
Center for Drug Regulation and Research 13
A. Documentary Requirements
(2) Proof of Business Name Registration
Must specify exact and complete address, where applicable:
Center for Drug Regulation and Research 14
• unit number • Floor • Building • Lot • Block
• street • Phase • Barangay • city/ municipality • province
A. Documentary Requirements
(3) Credentials of pharmacist and other qualified personnel
For pharmacist
• Valid PRC ID
• Certificate of Attendance to Licensing Seminar
Center for Drug Regulation and Research 15
A. Documentary Requirements
(3) Credentials of pharmacist and other qualified personnel
For other qualified personnel
• CV
• Training records to prove qualification
Center for Drug Regulation and Research 16
A. Documentary Requirements
(3) Credentials of pharmacist and other qualified personnel
Qualified personnel
• production manager
• quality assurance manager
• quality control manager
• authorized person for batch release
Center for Drug Regulation and Research 17
A. Documentary Requirements
(4) Risk Management Plan
Details on:
• identify, characterize, prevent or minimize risk
• PV activities and interventions to manage risks
Center for Drug Regulation and Research 18
A. Documentary Requirements
(5) Location Plan
• Sketch of the location
• “how to get there”
• Directions with landmarks
• GPS Coordinates
Center for Drug Regulation and Research 19
A. Documentary Requirements
(6) Site Master File
• Based on PIC/s GMP
Center for Drug Regulation and Research 20
A. Documentary Requirements
(7) Proof of Payment
• OR or payment slip
Center for Drug Regulation and Research 21
B. Evaluation and Compliance to cGMP
(1) Desktop Evaluation
• Initially reviewed by regional offices to determine compliance with Admin and tech reqts
Center for Drug Regulation and Research 23
B. Evaluation and Compliance to cGMP
(2) Inspection
In addition to the submitted application, the following documents will be verified during inspection:
• QMS
• Quality manual and SOPs
• Contract agreements
• Reference materials
Center for Drug Regulation and Research 24
B. Evaluation and Compliance to cGMP
(2) Inspection
a)Pre-opening inspection
b) Post-licensing inspection
• Routinely done
• maV may require
• Subject to regulatory action
Center for Drug Regulation and Research 25
B. Evaluation and Compliance to cGMP
(2) Inspection
Preliminary report shall be issued to the establishment after inspection
Center for Drug Regulation and Research 26
C. Application for Variation
1. Major Variation
a. Change of ownership
b. Additional product line
c. Transfer of location
d. Change of activity
Center for Drug Regulation and Research 27
C. Application for Variation
2. Minor Variation-Prior Approval
a. Change of business name
b. Zonal Change
Center for Drug Regulation and Research 28
C. Application for Variation
3. Minor Variation-Notification
a. Change of Pharmacist or other Qualified Personnel
b. Deletion of Activity
Center for Drug Regulation and Research 29
C. Application for Variation
Other changes – notified to FDA
Other variations may be added
Transfer of location – initial fee
Other variations – existing fee
Center for Drug Regulation and Research 30
Republic of the Philippines Department of Health
Food and Drug Administration
Center for Drug Regulation and Research 32
EXEMPTION IN PROVIDING ANOTHER PHARMACIST FOR
ADDITIONAL LICENSED ACTIVITY
Manufacturer Regulation
Exemption Exemption for Drug Manufacturer-Repacker and Drug Manufacturer-Trader pharmacist to handle another non-manufacturing activity except retailing provided the ff conditions are met
1. Activities belong only to one establishment (single business entity with same name registration and ownership)
Center for Drug Regulation and Research 33
Exemption Exemption for Drug Manufacturer-Repacker and Drug Manufacturer-Trader pharmacist to handle another non-manufacturing activity except retailing provided the ff conditions are met
2. Activities are confined only in one office/warehouse within the same premises
Center for Drug Regulation and Research 34
Republic of the Philippines Department of Health
Food and Drug Administration
Center for Drug Regulation and Research 35
RESPONSIBILITIES OF IMPLEMENTING OFFICES
Manufacturer Regulation
FDA and Regional offices
May call on the assistance of any department office and/or government agency for the effective implementation of its rules and regulations
Center for Drug Regulation and Research 36
LGUs Enjoined in monitoring licensed
establishments
Report to FDA any violative establishments
Center for Drug Regulation and Research 37
Republic of the Philippines Department of Health
Food and Drug Administration
Center for Drug Regulation and Research 38
TRANSITORY PROVISIONS
Manufacturer Regulation
Transitory Provision Submitted upon renewal for existing establishments
RMP
GPS Coordinates
Center for Drug Regulation and Research 39
Republic of the Philippines Department of Health
Food and Drug Administration
Center for Drug Regulation and Research 40
REPEALING/ SEPARABILITY CLAUSE
Manufacturer Regulation
Republic of the Philippines Department of Health
Food and Drug Administration
Center for Drug Regulation and Research 41
EFFECTIVITY
Manufacturer Regulation
Republic of the Philippines Department of Health
Food and Drug Administration
Center for Drug Regulation and Research 42
ANNEX A
Manufacturer Regulation
Initial LTO Application 1. Application Form
2. Proof of Business Name Registration
3. Credentials of Pharmacist and other Qualified Personnel
4. Risk Management Plan
5. Location Plan
6. Site Master File
7. Proof of Payment
8. Self-Assessment Toolkit
Center for Drug Regulation and Research 43
Renewal LTO Application
1. Application Form
2. Copy of Certifications issued as a result of LTO Variation
3. Proof of Payment (e.g., Official receipt or Landbank On-Coll payment slip)
4. Self-Assessment Toolkit
Center for Drug Regulation and Research 44
Reissuance of Lost or Destroyed LTO
1. Letter of Request
2. Affidavit of Loss or Destruction
3. Proof of Payment
Center for Drug Regulation and Research 45
Voluntary Cancellation 1. Letter of Request
2. Original LTO
Center for Drug Regulation and Research 46
Republic of the Philippines Department of Health
Food and Drug Administration
Center for Drug Regulation and Research 47
ANNEX B
Manufacturer Regulation
Change of Ownership
Center for Drug Regulation and Research 48
C change of ownership of the drug establishment
D
1. Letter of Request for Change
2. Application Form
3. Proof of business name registration reflecting the
new of owner
4. Deed of sale or transfer of rights of ownership
5. Proof of payment
6. Self-Assessment Toolkit
Additional Production Line
Center for Drug Regulation and Research 49
C Additional production line inside the manufacturer
D
1. Letter of Request for Change
2. Application Form
3. Updated Site Master File
4. Proof of payment
5. Self-Assessment Toolkit
Transfer of Location
Center for Drug Regulation and Research 50
C 1. Physical transfer of the drug establishment
2. Other variations (change of personnel, business
name) may also be included as long as the variation
is noted in the letter of request and the unique
requirements from the additional changes are
included. The fees remain the same as initial fee,
regardless of the additional variation.
Transfer of Location
Center for Drug Regulation and Research 51
D 1. Letter of Request for Change
2. Application Form
3. Proof of business name registration reflecting the
new address
4. New Location Plan
5. Updated Site Master File
6. Proof of payment
7. Self-Assessment Toolkit
Change of Activity
Center for Drug Regulation and Research 52
C 1. Additional activity engaged by the manufacturer (e.g. LTO as
Manufacturer-Repacker with additional activity as
Manufacturer)
2. Change from the initially licensed activity (e.g. LTO as
Manufacturer-Repacker to Manufacturer-Packer).
D
1. Letter of Request for Change
2. Application Form
3. Updated Site Master File
4. Proof of payment
5. Self-Assessment Toolkit
Change of Business Name
Center for Drug Regulation and Research 53
C 1. Change only in the business name
2. No transfer of location or change of ownership.
D
1. Letter of Request for Change
2. Application Form
3. Proof of business name registration reflecting the
new name of the business/drug establishment
4. Proof of payment
5. Self-Assessment Toolkit
Zonal Change
Center for Drug Regulation and Research 54
C change of the name/number of the street/building
without physical transfer of the establishment.
D
1. Letter of Request for Change
2. Application Form
3. Document issued by the local municipality as proof of
zonal change
4. Proof of payment
5. Self-Assessment Toolkit
Change of Pharmacist or Other Qualified Personnel
Center for Drug Regulation and Research 55
C 1. There is a change of the identified pharmacist
and/or other qualified personnel
2. For multiple pharmacists employed, the identified
responsible pharmacist that will be
replaced/changed shall be required to apply for
variation; the same goes for the other qualified
personnel
Change of Pharmacist or Other Qualified Personnel
Center for Drug Regulation and Research 56
D 1. Letter of Request for Change
2. Application Form
3. Credentials of the pharmacist and/or other
qualified personnel
4. Proof of payment
5. Self-Assessment Toolkit
Deletion of Activity
Center for Drug Regulation and Research 57
C deletion of any approved/added manufacturing
activity
D
1. Letter of Request for Change
2. Application Form
3. Termination of contract or conformance letter
4. Proof of payment
5. Self-Assessment Toolkit
Republic of the Philippines Department of Health
Food and Drug Administration
Center for Drug Regulation and Research 58
Situation 1
MMZ Manufacturing, Inc. with an existing and valid LTO (CDRR-RIV-DM-123) wishes to transfer their ownership rights to ESM Laboratories, Inc. due to financial crisis.
Republic of the Philippines Department of Health
Food and Drug Administration
Center for Drug Regulation and Research 59
Situation 2:
Company ABC holds an existing and valid LTO (CDRR-RIII-DM-001) as Repacker located at 401 Industrial Park, San Vicente, Bulacan. Since the business is doing well, the said company wants to venture manufacturing of its own product.
Republic of the Philippines Department of Health
Food and Drug Administration
Center for Drug Regulation and Research 60
Situation 3:
JST Pharmaceuticals, a well-known manufacturer of generic medicines currently located at No. 5 Saint. James St., Brgy.,Ilaya, Zone 4, Dasmariñas, Cavite will change its address to No. 5 Saint. James St., Brgy.,Ilaya, Zone 3, Dasmariñas, Cavite due to unavoidable circumstance mandated by municipality.
Republic of the Philippines Department of Health
Food and Drug Administration
Center for Drug Regulation and Research 61
Situation 4:
Amethyst Labs. Corp., is a holder of a newly issued LTO as Drug Manufacturer located at Laguna. Expanding its business, the management decided to relocate to a bigger place and replace its business name to One World Laboratories while retaining the current owners. Due to these major changes, their Registered Pharmacist decided to leave.
Republic of the Philippines Department of Health
Food and Drug Administration
Center for Drug Regulation and Research 62
Situation 5:
Company EFG is an existing manufacturing establishment with valid LTO located at Cavite and currently into processing of non-penicillin products. During the validity of LTO the company wants to widen its scope as a manufacturer and will try to engage in processing penicillin related products.
Republic of the Philippines Department of Health
Food and Drug Administration
Center for Drug Regulation and Research 63
Situation 6:
Cigna Laboratories located in 706 Industrial Rd., San Miguel Bulacan has an existing LTO as Drug Manufacturer (CDRR-NCR-DM-101) with validity until 30 September 2014. Due to inavoidable circumstance, the pharmacist-in-charge filed her resignation.
Republic of the Philippines Department of Health
Food and Drug Administration
Center for Drug Regulation and Research 64
Situation 7:
Leo Manufacturers currently owned by the Monreal Group of Companies has a valid and existing LTO as Packer-Repacker. Due to a controversy, its clients started to terminate their contracts. Due to this incident, to maximize the remaining resources and to cover up for their losses, the company decided to stop their repacking activity and would just remain as a packer.